Infectious Disease In-vitro Diagnostics Market (By Product: Instruments, Reagents; By Application MRSA, Streptococcus; By Technology: Immunoassay, Molecular Diagnostics; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Published Date : Apr 2021 | No. of Pages : 250 Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Infectious Disease In-vitro Diagnostics Market, By Product

7.1.  Infectious Disease In-vitro Diagnostics Market, by Product Type, 2021-2030

7.1.1.    Instruments

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Reagents

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Services

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Infectious Disease In-vitro Diagnostics Market, By Technology

8.1.  Infectious Disease In-vitro Diagnostics Market, By Technology, 2021-2030

8.1.1.    Immunoassay

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Molecular Diagnostics

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Microbiology

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Infectious Disease In-vitro Diagnostics Market, By Application

9.1.  Infectious Disease In-vitro Diagnostics Market, By Application, 2021-2030

9.1.1.    MRSA

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Streptococcus

9.2.  Market Revenue and Forecast (2016-2030)

9.2.1.    Clostridium Difficile

9.3.  Market Revenue and Forecast (2016-2030)

9.3.1.    VRE

9.4.  Market Revenue and Forecast (2016-2030)

9.4.1.    CRE

9.5.  Market Revenue and Forecast (2016-2030)

9.5.1.    Respiratory Virus

9.6.  Market Revenue and Forecast (2016-2030)

9.6.1.    Candida

9.7.  Market Revenue and Forecast (2016-2030)

9.7.1.    TB and Drug-resistant TB

9.8.  Market Revenue and Forecast (2016-2030)

9.8.1.    Gastro-intestinal Panel Testing

9.9.  Market Revenue and Forecast (2016-2030)

9.9.1.    Chlamydia

9.10.        Market Revenue and Forecast (2016-2030)

9.10.1.  Gonorrhea

9.11.        Market Revenue and Forecast (2016-2030)

9.11.1.  HPV

9.12.        Market Revenue and Forecast (2016-2030)

9.12.1.  HIV

9.13.        Market Revenue and Forecast (2016-2030)

9.13.1.  Hepatitis C

9.14.        Market Revenue and Forecast (2016-2030)

9.14.1.  Hepatitis B

9.15.        Market Revenue and Forecast (2016-2030) )

9.15.1.  COVID-19

9.16.        Market Revenue and Forecast (2016-2030) )

9.16.1.  Others

9.16.1.1.      Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Infectious Disease In-vitro Diagnostics Market, By End-Use

10.1.        Infectious Disease In-vitro Diagnostics Market, By End-Use, 2021-2030

10.1.1.  Point of care

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Central Laboratories

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Others

10.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Infectious Disease In-vitro Diagnostics Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2016-2030)

11.1.2.  Market Revenue and Forecast, By Technology (2016-2030)

11.1.3.  Market Revenue and Forecast, By Application (2016-2030)

11.1.4.  Market Revenue and Forecast, By End-Use (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.5.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.1.5.3.      Market Revenue and Forecast, By Application (2016-2030)

11.1.5.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.6.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.1.6.3.      Market Revenue and Forecast, By Application (2016-2030)

11.1.6.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2016-2030)

11.2.2.  Market Revenue and Forecast, By Technology (2016-2030)

11.2.3.  Market Revenue and Forecast, By Application (2016-2030)

11.2.4.  Market Revenue and Forecast, By End-Use (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.5.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.2.5.3.      Market Revenue and Forecast, By Application (2016-2030)

11.2.5.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.6.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.2.6.3.      Market Revenue and Forecast, By Application (2016-2030)

11.2.6.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.7.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.2.7.3.      Market Revenue and Forecast, By Application (2016-2030)

11.2.7.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.8.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.2.8.3.      Market Revenue and Forecast, By Application (2016-2030)

11.2.8.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2016-2030)

11.3.2.  Market Revenue and Forecast, By Technology (2016-2030)

11.3.3.  Market Revenue and Forecast, By Application (2016-2030)

11.3.4.  Market Revenue and Forecast, By End-Use (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.5.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.3.5.3.      Market Revenue and Forecast, By Application (2016-2030)

11.3.5.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.6.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.3.6.3.      Market Revenue and Forecast, By Application (2016-2030)

11.3.6.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.7.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.3.7.3.      Market Revenue and Forecast, By Application (2016-2030)

11.3.7.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.8.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.3.8.3.      Market Revenue and Forecast, By Application (2016-2030)

11.3.8.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2016-2030)

11.4.2.  Market Revenue and Forecast, By Technology (2016-2030)

11.4.3.  Market Revenue and Forecast, By Application (2016-2030)

11.4.4.  Market Revenue and Forecast, By End-Use (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.5.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.4.5.3.      Market Revenue and Forecast, By Application (2016-2030)

11.4.5.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.6.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.4.6.3.      Market Revenue and Forecast, By Application (2016-2030)

11.4.6.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.7.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.4.7.3.      Market Revenue and Forecast, By Application (2016-2030)

11.4.7.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.8.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.4.8.3.      Market Revenue and Forecast, By Application (2016-2030)

11.4.8.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2016-2030)

11.5.2.  Market Revenue and Forecast, By Technology (2016-2030)

11.5.3.  Market Revenue and Forecast, By Application (2016-2030)

11.5.4.  Market Revenue and Forecast, By End-Use (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.5.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.5.5.3.      Market Revenue and Forecast, By Application (2016-2030)

11.5.5.4.      Market Revenue and Forecast, By End-Use (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.6.2.      Market Revenue and Forecast, By Technology (2016-2030)

11.5.6.3.      Market Revenue and Forecast, By Application (2016-2030)

11.5.6.4.      Market Revenue and Forecast, By End-Use (2016-2030)

Chapter 12.  Company Profiles

12.1.              BD

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              bioMérieux SA

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Abbott

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Quidel Corporation

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              OraSure Technologies, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Hologic, Inc. (Gen Probe)

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Danaher

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              QIAGEN

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              F. Hoffmann-La Roche, Ltd.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Siemens Healthineers AG

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Bio-Rad Laboratories, Inc.

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Cancer Supportive Care Drugs Market (By Therapeutic Class: G-CSFs, Anti-emetics, ESAs, Bisphosphonates, Opioids, NSAIDs & Others)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    eHealth Devices Market( By Type: Blood Pressure Meters, Fever Meters, Glucose Meters, Care Phone/Social Alarms)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Tracheostomy Products Market (By Demographics: Adults, Paediatrics/Neonatal; By Type: Tracheostomy Tubes, Ventilation Accessories ; By End Use: Hospitals & Surgery Centers, Ambulatory Care Centers, Home Care Settings, Others; By Technique) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Smart Blood Pressure Monitoring Devices Market (By Type: Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor Finger Blood Pressure Monitor; By Technology: Wi-Fi Based/4G, Bluetooth Based)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Laparoscopic Electrodes Market (By Application: Bariatric, General Surgeries; By Product: Monopolar, Bipolar Electrodes; By End User: Hospital, Ambulatory)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...